logo-loader

Psyched Wellness shares key milestone in Maximum Tolerated Dosage study of Amanita Muscaria extract

Published: 14:44 02 Mar 2021 EST

Psyched Wellness Ltd (CSE:PSYC) (OTCQB:PSYCF) CEO Jeffrey Stevens tells Proactive the life sciences company revealed the results from its Maximum Tolerated Dosage (MTD) study of AME-1 conducted by KGK Science.

Stevens says this key milestones gives the group the MTD safe for consumption. Now, the group will move into a 14-day and then a 90-day oral toxicity study.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

56 minutes ago